HANUMANT GAMBHIRE; MONICA GULATI; SACHIN KUMAR SINGH; ATUL NASA; NEELU GOEL. AN OVERVIEW OF US FDA WARNING LETTERS TO INDIAN PHARMACEUTICAL INDUSTRIES FOR cGMP VIOLATIONS PERTAINING TO STERILE PRODUCTS. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 29, n. 03, p. 1845–1863, 2022. DOI: 10.53555/jptcp.v29i03.7242. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/7242. Acesso em: 18 nov. 2024.